TissueGen, Inc.
TissueGen is a medical device company whose patented technology
enables creation of biodegradable polymer devices with unique drug
delivery capabilities. Because its proprietary manufacturing
process occurs at room temperature, the company can incorporate
biologically active agents (e.g. therapeutic proteins) into its
devices. TissueGen is focusing initial product development efforts
on vascular stents - an application with a large dynamic market and
for which our technology is ideally suited. By using biodegradable
polymers with second-generation drugs such as growth factors or
enzymes, TissueGen is designing vascular stents that offer
breakthrough treatment capability.
For future opportunities, the company's technology is suitable
to many additional markets and applications, providing a
diversified pipeline of products or licensing opportunities for
continued growth.